Nakanishi, K.; Tanaka, C.; Kanda, M.; Miyata, K.; Furukawa, K.; Maeda, O.; Shimizu, D.; Sugita, S.; Kakushima, N.; Furune, S.;
et al. Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer. Cancers 2023, 15, 5197.
https://doi.org/10.3390/cancers15215197
AMA Style
Nakanishi K, Tanaka C, Kanda M, Miyata K, Furukawa K, Maeda O, Shimizu D, Sugita S, Kakushima N, Furune S,
et al. Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer. Cancers. 2023; 15(21):5197.
https://doi.org/10.3390/cancers15215197
Chicago/Turabian Style
Nakanishi, Koki, Chie Tanaka, Mitsuro Kanda, Kazushi Miyata, Kazuhiro Furukawa, Osamu Maeda, Dai Shimizu, Shizuki Sugita, Naomi Kakushima, Satoshi Furune,
and et al. 2023. "Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer" Cancers 15, no. 21: 5197.
https://doi.org/10.3390/cancers15215197
APA Style
Nakanishi, K., Tanaka, C., Kanda, M., Miyata, K., Furukawa, K., Maeda, O., Shimizu, D., Sugita, S., Kakushima, N., Furune, S., Kawashima, H., Ando, Y., Ebata, T., & Kodera, Y.
(2023). Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer. Cancers, 15(21), 5197.
https://doi.org/10.3390/cancers15215197